Sign in
CompletedNo phase

Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia With Daridorexant in Canada

Key facts

Who runs it
PeriPharm
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
90 people enrolled
Started
20 Jun 2024
Ended
19 May 2026
Type of study
Observational
Treatments tested
  • Daridorexant 50 mg
Record updated
27 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Signed ICF prior to any study-mandated procedure
  • Has received a first prescription of daridorexant 50 mg to treat insomnia, treatment start has not exceeded 7 days prior to enrollment
  • Ability to read and understand French or English

Who cannot take part

  • Taking a concomitant medication to treat insomnia
  • Already started daridorexant more than 7 days prior to enrollment.The 7-day period is necessary to allow flexibility between the time of prescription and PROxy first contact to participant. Beyond this 7-day period, patients may already have experienced benefits from daridorexant. To minimize bias in baseline results, these patients will be excluded
  • History of daridorexant use in the past (i.e., samples provided by the physician before prescription)
  • Patients participating in a clinical trial

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this observational study is to evaluate the impact of daridorexant on quality of life, work productivity and insomnia symptoms in Canadian adults suffering from insomnia.

The group in the trial

  • daridorexant

    Patients who have been newly prescribed oral tablets of daridorexant 50 mg to treat their insomnia

    Treatment: Daridorexant 50 mg

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
27 May 2026